Oral mucous membrane pemphigoid: updates in diagnosis and management

Loading...
Thumbnail Image
Penn collection
School of Dental Medicine::Departmental Papers (Dental)
Degree type
Discipline
Dentistry
Subject
Autoantibodies / therapeutic use; Mucous Membrane ; pathology; Oral Ulcer; Pemphigoid, Benign Mucous Membrane; Bullous; diagnosis; drug therapy
Funder
Grant number
Copyright date
2024
Distributor
Related resources
Author
Roopali Kulkarni; Eric T. Stoopler; Thomas P. Sollecito
Contributor
Abstract

Mucous membrane pemphigoid (MMP) is a rare, immune-mediated, vesiculobullous disease that predominantly affects the oral cavity and conjunctiva. In MMP, autoantibodies are directed against hemidesmosomal proteins in the basement membrane zone, most commonly BP180. Clinical signs and symptoms include gingival desquamation, erosions, and ulcerations. Differential diagnoses include other immune-mediated blistering diseases, such as bullous pemphigoid. Definitive diagnosis is reached through history taking, physical examination, tissue biopsy and/or serology testing. MMP, although not curable, is typically managed with topical or systemic corticosteroids, in addition to immunosuppressive therapies and biologic agents in recalcitrant cases. Untreated MMP can lead to life-threatening complications, such as blindness. As a condition that affects the oral cavity, it is important that dentists understand how to recognise, diagnose and manage the disease.

Advisor
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Publication date
2024-02-23
Journal title
British Dental Journal
Volume number
Issue number
Publisher
The Authors
Journal Issue
Comments
Recommended citation
Collection